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mRNA sequencingDown syndrome (DS, trisomy 21), is the most common viable chromosomal disorder, with an incidence of 1 in
800 live births. Its phenotypic characteristics include intellectual impairment and several other developmental
abnormalities, for the majority of which the pathogenetic mechanisms remain unknown. In this “Data in Brief”
paper, we sum up the whole genome analysis by mRNA sequencing of normal and DS induced pluripotent
stem cells that was recently published by Hibaoui et al. in EMBO molecular medicine.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Experimental design, materials and methods
Cell culture and iPSC derivation
Primary fetal skin ﬁbroblasts were isolated from monozygotic
twins discordant for trisomy 21 [1]: Twin-N for the normal ﬁbro-
blasts and Twin-DS for ﬁbroblasts carrying trisomy 21 anomaly.
These samples were obtained post mortem and the study was ap-
proved by the ethics committee of the Geneva University Hospital.
Normal (Twin-N-iPSCs) and Down syndrome (Twin-DS-iPSCs) in-
duced pluripotent stem cells (iPSCs) were established by transduc-
ing the parental ﬁbroblasts (Twin-N and Twin-DS, respectively)
with polycistronic lentiviral vectors expressing OCT4, SOX2, KLF4
and c-MYC genes [2,3]. The generated iPSCs were cultured on
human foreskin ﬁbroblasts (ATCC, CCD 1112Sk, Manassas, USA)
that were mitotically inactivated by irradiation at 35 Gy before
seeding on a gelatin-coated 6-well plate at 3.5 × 105 cells/plate.
IPSC colonies were maintained with daily changes in Knock-outthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. Schematic representation of Twin-N and Twin-DS ﬁbroblast reprogramming
into Twin-N-iPSCs and Twin-DS-iPSCs. Primary fetal skin ﬁbroblasts were isolated
frommonozygotic twins discordant for trisomy 21 (Twin-N for the normal ﬁbroblasts
and Twin-DS for the ﬁbroblasts carrying the trisomy 21 anomaly) and used to estab-
lish normal and DS induced pluripotent stem cells (iPSCs) using OCT4, SOX2, KLF4 and
c-MYC genes: Twin-N-iPSCs for the normal iPSCs and Twin-DS-iPSCs for the iPSCs car-
rying trisomy 21 [4].
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serum replacement, 1 mM L-glutamine, 100 μM non-essential
amino acids, 100 μM 2-mercaptoethanol, 50 U/mL penicillin and
50 mg/mL streptomycin (all from Gibco, Invitrogen, Basel,
Switzerland) and 100 ng/mL human basic ﬁbroblast growth factor
(bFGF, Peprotech, London, UK). All iPSC lines were passaged by man-
ual dissection of cell clusters in the presence of 10 μMROCK-inhibitor
Y-27632 (Sigma-Aldrich, Buhs, Switzerland) [4].
RNA extraction and gene expression analysis by mRNA sequencing
Total RNA was extracted from the cell lines, using the QIAGEN
(Hilden, Germany) RNeasy MiniKit according to the manufacturer's
protocol (Invitrogen). RNA integrity and quantity were assessed
with an Agilent (Santa Clara, CA, USA) 2100 bioanalyser, using
RNA 6000 nanochips. mRNA-Seq libraries were prepared from
500 ng of total RNA using the Illumina TruSeq™ RNA Sample Prep-
aration kit (Illumina RS-930-2001), following the manufacturer's
instructions. Libraries were sequenced on the Illumina HiSeq 2000
instrument to generate 100 bp paired-end reads. Those reads
were mapped against the genome (hg 19) using the default param-
eters of the Burrows–Wheeler Aligner (BWA) [5]. An expression
signal was detected in at least one sample for 20456 genes (com-
prising also non-coding RNA). For each gene, the level of expression
was determined by calculating the exon coverage (custom pipeline)
and normalizing in Reads Per Kilobase per Million (RPKM). Twin-
DS-iPSCs and Twin-N-iPSCs samples were sequenced in three and
four biological replicates, respectively, starting from different RNA
preparations. Differential expression between Twin-N-iPSCs and
Twin-DS-iPSCs was assessed using the default parameters of
EdgeR (version 2.4.6) [6] and DESeq (version 1.6.1) [7] programs
in R (version 2.14.0). Only the genes with more than 1 read per mil-
lion in at least 3 replicates were conserved for this analysis.
Bonferroni correction was applied to adjust for multiple testing. A
gene was considered differentially expressed if the Bonferroni-
corrected P-value was lower than 0.01 with both methods. Analysis
of the functional annotations associated with the differentially
expressed genes was performed using DAVID (Database for Annota-
tion, Visualization and Integrated Discovery) [8,9].
2. Discussion
Since the discovery that Down syndrome (DS) is caused by a tri-
somy of chromosome 21 (HSA21), a major challenge in DS research
has been the recapitulation of DS phenotype and the identiﬁcation
of the mechanisms by which the extra copy of HSA21 leads to DS
phenotypes [10]. In this respect, disease-speciﬁc iPSCs has opened
up a new exciting avenue for the modeling and the correction of
the phenotypes associated with several neurological diseases
(reviewed in [11]). In our recent study, fetal skin ﬁbroblasts isolat-
ed from monozygotic twins discordant for trisomy 21 [1], were
used to establish normal and DS induced pluripotent stem cells
(iPSCs): Twin-N-iPSCs for the normal iPSCs and Twin-DS-iPSCs for
the iPSCs carrying trisomy 21 [4] (Fig. 1). As expected for cells
that have acquired a pluripotent state, Twin-N-iPSCs and Twin-
DS-iPSCs expressed markers of pluripotent cells, showed alkaline
phosphatase activity, and differentiated in vitro and in vivo into
the three embryonic germ layers mesoderm, ectoderm and endo-
derm [4].
Then, whole transcriptome analysis was performed using
mRNA-Sequencing and the normalized gene expression levels
were compared between Twin-N-iPSCs and Twin-DS-iPSCs. Differ-
ential expression analysis was performed using the statistical R
packages EdgeR and DESeq. Under these conditions, we obtained a
list of 624 upregulated and 580 downregulated genes expressed
in Twin-DS-iPSCs in comparison with Twin-N-iPSCs (listed inTable 1). The gene ontology (GO) analysis of the 624 genes upreg-
ulated in Twin-DS-iPSCs using DAVID showed enrichment for func-
tions predominantly related to the regulation of RNA metabolic
processes and regulation of transcription. The GO analysis of the
580 genes downregulated in Twin-DS-iPSCs revealed signiﬁcant en-
richment for genes involved in multiple developmental processes
including embryonic development and morphogenesis, organ de-
velopment and morphogenesis, cellular adhesion and others [4].
Such alterations observed at the iPSC level illustrate the develop-
mental disease transcriptional signature of Down syndrome.
Considering our results and the recent studies recapitulating and
rescuing the phenotypes associated with several neurological dis-
eases using pluripotent stem cell-based models (reviewed in
[11]), we believe that a combination of the transcriptional proﬁling
with the possibility to derive in principle all cell type relevant for
the disease will contribute to a better understanding of the initia-
tion and the development of DS and ultimately to the design of
new therapies.Conﬂict of interest
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Table 1
List of the differentially expressed genes between Twin-N-iPSCs and Twin-DS-iPSCs.
Conservative list of 624 upregulated and 580 downregulated genes expressed in Twin-DS-iPSCs in comparison with Twin-N-iPSCs obtained with the statistical R packages EdgeR and
DESeq (with a Bonferroni-corrected P-value lower than 0.01).
Conservative list of 580 downregulated genes expressed in Twin-DS-iPSCs in
comparison with Twin-N-iPSCs (with a Bonferroni-corrected P-value lower than 0.01).
Conservative list of 624 upregulated genes expressed in Twin-DS-iPSCs in comparison
with Twin-N-iPSCs (with a Bonferroni-corrected P-value lower than 0.01).
LOC145845, GPR116, XIST, TSIX, HOXA2, DPP6, FAM181A, MMRN1, SOX1, POU3F2, DMRT2,
RXRG, HOXB3, GALP, DLX1, RFX4, HGC6.3, NKX2-3, APLNR, SCRG1, HOTAIRM1, RHOJ,
HOXB2, NR2F1, SERPINA3, CLEC1A, LOC440925, SOX17, H19, DKK2, SP5, VCAM1,
CLEC3A, SMOC1, CLDN16, WNT1, NTRK2, TBX15, BMP5, CDH5, OTOF, FGF3, MX2, LRRN3,
RD3, HABP2, BCHE, EPHA3, EYA4, ISLR2, CDH10, CCDC33, PAX3, LOC283731, DACH1,
FLJ31485, COL2A1, BAHCC1, PCDH10, OLIG3, LRRC7, CDH6, RFTN2, CYTL1, SPATA16,
ATOH8, ASXL3, DLX2, LGR5, GBX2, MAPK10, SLITRK1, CLEC18B, EOMES, PAX2, ZBTB16,
SP8, GLRA1, LOC339535, F13A1, SOX5, RNASE1, AFF3, CCDC48, EGFLAM, UNC5C, GATA4,
FZD10, FGF17, NCALD, NCRNA00261, GDF10, MEIS2, CNTFR, NDNF, APOLD1, CDH9,
LRRC17, TLR4, EBF2, MGP, MEF2C, ZEB2, FOXA1, SERPINA5, RNF165, GATA6, TAGLN3,
FST, GJA5, SLC6A16, ARHGDIB, SH3TC1, LOC149837, FGF9, SULT1C4, FOXA2, C20orf103,
ANGPTL1, MTTP, EGR3, NEFM, KCNJ16, SLCO1C1, NKAIN2, ST8SIA2, SOX6, ZNF503, SSPO,
EGR2, CDH20, MSX1, SOX9, PPP1R14C, RWDD2B, IGF2AS, TRPC4, RBMS3, WDR52,
EPHB3, CXXC4, FBLN7, WDR60, LOC100506385, FZD2, ZNF703, FZD1, CRB2, CX3CL1,
TSHZ1, IHH, CD93, GAD1, EFNB1, HNMT, C10orf140, ZNF521, HOGA1, CDH2, CNTN3,
CDKN1C, SPOCK3, ADAMTS9, RAI1, LHX1, LOC100130855, MUM1L1, C5, BOC, WLS,
KIAA1456, S1PR1, PYGO1, SHOX2, BEAN1, LRP2, LOC284276, THPO, SYNPO, DIO3,
RNF212, ST6GALNAC5, EPHA4, USP3, STEAP4, TBX10, FLRT3, DRP2, SCN1A, PAX8, SLC9A9,
C1orf213, GLYATL2, HMGCLL1, SLC8A3, ZNF467, F2RL2, IER5L, SULT1A1, SULT1A2,
ZNF436, MECOM, LOC646999, TWIST1, SLITRK5, IL2RB, CLDN18, LIX1L, CHRD, TBX20,
SLC44A5, SATB2, TMEM121, WNT10B, LOC100505576, IGFBP5, CHRNA9, RBM24,
PKNOX2, C15orf2, EDNRB, FGFBP3, LOC144571, FOSB, PDE10A, TRIL, CCDC146, ACCN2,
ZNF382, KCNQ1, FIGF, LOC386597, FAM65B, SDK2, KLHL4, GLT25D2, LOC100289178,
PREX1, GUSBP1, RIMBP3, TBX5, DOCK10, LHFP, CRABP1, RHOB, LSAMP, NRGN, NRP2,
TLR5, NR2F2, ASB9, NFIA, CCDC125, GLDN, TMPRSS5, NCRNA00245, C1QTNF3, COLQ,
ZEB1, C6orf118, CHD7, HHAT, SIX1, SCUBE3, DUSP4, SETBP1, SEZ6L, LOC100505881,
IQSEC3, BTBD17, VASH1, SORCS2, C5orf38, TMEM169, FLI1, ADCY8, PMFBP1, LYPD1,
FRMD4A, RGAG4, MLLT3, SP140L, CHCHD2, C3orf70, DUSP27, PHC2, ZNF518B, PDE4D,
MLLT6, MBNL2, FAM38B, C14orf80, NOVA1, PRR4, COL11A1, PRMT8, LGI4, DNAH9,
POMZP3, IRX2, DAGLA, MATN3, SDSL, C15orf38, CDH4, PCDHGB6, SRCIN1, SIM2, GYPC,
FRMD4B, ONECUT2, STK31, HTRA3, LOC100506190, COL13A1, TMEM132E, EFNB2,
FHOD3, CSRNP3, WFIKKN1, CITED1, CAMK2D, PMP22, SYTL2, DENND2A, SOCS3, ZNF704,
COLEC12, PRR5L, PDK1, TNFAIP6, DCHS1, PCDHGC4, CUEDC1, FIGNL2, TET2, TBC1D9,
PNMA2, GRASP, CTCFL, EFNA5, SNCG, LIMCH1, GSTM3, PCDHGC5, RP9P, LIPG, PCDHGC3,
SEMA3A, CRNDE, SLC35F1, KMO, ZADH2, PCDHGA10, PCDHGA9, LRRC27, PCDHGA2,
PCDHGA1, BAI1, PCDHGA5, PCDHGA7, PCDHGB1, GFRA2, PCDHGA8, PIK3R1, MGC45800,
CPNE8, PCDHGB3, LOC255480, PCDHGA3, EDNRA, PCDHGB2, ARRB1, MXRA5, PCDHGA6,
PCDHGB7, ZSWIM6, PCDHGA12, PLEKHA4, BTG2, WIPF1, SOX10, PCDHGA4, IFT140,
MDFIC, LOC283624, PCDHGB4, TNRC18, KIAA0101, TRIB2, PCDHGB5, SERTAD4, COL9A2,
RNASEL, SYT12, ARC, ID3, ZIC2, IFITM2, LPAR6, ESPNL, HECTD2, H2AFY2, CD99L2,
PCDHGA11, NIN, STK32B, SDC2, MN1, ZNF664, COL5A2, SDC3, LPHN2, RNF175,
LGALS3BP, SPRY2, CPE, APBA2, ANKRD6, CPXM1, SPRY1, C11orf9, SSBP2, TMSB15A, FZD3,
CADM1, NTN1, HTR7, ANTXR2, UHRF1, CCDC167, PCDH18, FAM84A, FKBP7, AADAT,
TTC28, BMI1, CDK6, S1PR3, TTC3, PALLD, COMMD3-BMI1, ADAMTS10, KLF12, H2AFY,
LMF1, OPN3, TTC3P1, SFRP1, LOC730101, WDR90, FAM115A, MXD4, KIAA1644, FAM89B,
CCNG2, ITPKB, TCHP, ST3GAL3, MEX3B, BCL7A, ZNF862, ZNF624, DNAJC15, HEG1, CO-
L4A2, SRRM5, EFS, LCOR, H1F0, MDFI, ALG10B, ENC1, DACT3, SPSB4, SUFU, RNF144A,
RNF19A, ANGPTL2, PFKFB4, CD47, GPR153, ITGA4, SEMA5A, PIK3R3, COL9A1, CARD8,
ZHX2, ARHGEF40, ELFN1, ZNF280C, C5orf24, GPR161, MCF2L, CAP2, GPSM1, CDK19,
CCDC80, GSTA4, PGAP1, KDM6B, CCDC50, ULK2, CCND2, SESTD1, ADAMTS4, SENP7,
SMAD3, CSF1, DDHD2, MAP1B, DENND5B, TCF12, YPEL1, PCBP4, SEMA6C, EMILIN1,
CPNE2, IGFBP2, MAP7D1, HDAC6, KLF6, JUN, MSI1, ODZ3, APPBP2, FAM176B, C1RL,
TMEM123, RGMA, CHD3, MEIS3P1, VIM, FAM113A, MEIS3, CSPG4, PLEKHO1, C6orf89,
GPR173, KLF3, DOCK1, NAB1, LOXL2, F2R, ZFP90, SLC35E2, CMTM3, GPX7, LOXL1, LPIN2,
SVIL, BTBD6, PDLIM7, TYMS, SHF, ENOSF1, RALGDS, B3GALNT1, GALC, B3GNT5, DOCK7,
ZIC5, CDK14, ITGA5, MEGF6, FAM172A, ST5, PAM, STK40, ZMIZ1, EGLN1, JAG1, BNIP3L,
UBE2J1, EMID2, BAZ1A, ZNF740, COL4A1, HOOK3, TFDP2.
MTHFD1, SLC1A5, PRR13, KIAA0368, TWISTNB, EIF3B, LIN28A, PODXL, DNAJB6, FOXO1,
URB1, TPST2, SALL4, MTL5, CARS, GGCT, AKIRIN1, ACADSB, ZNF134, FAM98A, FAM83G,
CLU, ZNF770, VOPP1, RRP12, CDCA7L, PDZD2, GART, SGMS1, IPW, CXADR, ANKRD33B,
PFKFB2, CPVL, RAB7L1, PRPS2, ZNF101, MRPS21, RBPMS2, MAD2L2, IDH3A, NME2,
KIAA0415, COL9A3, RBBP7, ZNF605, ZNF695, EIF2S3, TBC1D8, PAR-SN, BNC2, TBC1D23,
KIAA1543, C21orf59, GCNT2, NFKBIB, C20orf27, C1orf183, PSMA2, MID1IP1, DDX21, CSTB,
AARS, MREG, ITPK1, FAM110A, ABCA1, PRKCB, LOC643988, TEX15, CBS, SLC35F2, EDEM2,
SESN2, TRIM14, DCN, AEN, DIAPH2, HOOK1, SLC39A14, DPP4, CDS1, ENPP1, B3GNT7,
RLTPR, SLC4A5, CLDN6, CCRN4L, PPAP2A, FOXA3, RNF125, ZNF589, MTHFD2, ELOVL4,
WIPF3, FBXO41, TBRG4, DRAM1, NUDT6, SPSB2, EIF2S2, PRKAR2B, PHC1, ASTN2, EHHADH,
FDXR, USP28, CEBPB, PPARGC1B, PACSIN3, MRPL32, USO1, PPIC, FAM160A1, MRPS17,
INADL, MYO1E, EPHA1, WFDC2, CD24, PWP2, GRTP1, SKA3, SYT14, PPM1H, ACOT8, MTA3,
DND1, GNAO1, CILP2, KCNS3, GLDC, FGFR4, F11R, C1QTNF1, POLR3G, PSPH, TFAP2C,
OLFM2, GREM1, TARS, CCDC69, B3GALT5, CDC42BPG, FOXH1, VWDE, TOMM7, FAM155B,
GCH1, TMEM132D, VSNL1, SIRT1, SEMA4A, DPPA4, ZBTB3, ATCAY, FUT1, ALDH1L2, FOSL1,
TJP2, SLC44A1, GRM4, ZNF85, TMEM200A, NPTXR, JARID2, GLI1, NACAD, PMAIP1, LLGL2,
KCTD14, MBP, FKBP4, ZNF470, HCN2, FBXO27, RBM47, CYCS, POU5F1P3, CHST4, PLS3,
RIPK4, SYNGR3, YBX2, SGK1, NFE2L3, PAIP2B, POU5F1B, C8orf44-SGK3, ASNS, SLC7A5,
PDK3, LOC100505761, SLC24A2, SLC43A1, GALNT6, ZNF625, CADPS2, MYC, ZNF525,
ZNF613, SCAMP5, RYR1, C8orf42, ASS1, ADM2, CCDC3, LOC100506930, ZNF483, DEPTOR,
UGP2, FGF2, RAP1GAP2, GNPTAB, PPP2R2C, FZD5, SKIL, SYT13, HPSE, C19orf66, VSIG10,
TMEM184A, PRKCQ, RASGRP2, TRIM6, SPR, GARS, CGNL1, UGT3A2, USP44, OSBPL10, CGN,
MAFK, UPP1, MRS2P2, MT1X, ZNF398, PHLDA3, INPP5F, NMNAT2, PRSS16, SLCO4C1,
ZYG11A, SLC7A3, ZSCAN10, APOE, MYBPC2, MRM1, CCDC64, MRS2, RARRES2, ARHGEF19,
NANOG, PDLIM1, KCNC3, SPINT2, CARD11, COL10A1, TMEM38A, SYT3, TXLNG, PPL,
ELOVL7, TUBA4A, COMMD7, FRAT2, MFSD6, HERC6, RASIP1, GPR143, FAM101B, ANKRD5,
SPINT1, PPP2R2B, SLC1A6, SLC16A10, CLDN9, KSR2, ZNF649, ICOSLG, GPR113, PPP1R16B,
GYLTL1B, DOCK9, ZNF165, TC2N, TUBB4, PRKAR1B, IFI30, GRB7, ZNF595, L1TD1, LHFPL4,
RNF144B, DENND1C, REEP6, MAP7, PRR5-ARHGAP8, CDH3, CDCP1, EPCAM, C3,
LOC100130899, SCNN1A, ARHGAP8, AGPAT9, SGK3, GLB1L3, CDH1, LAMA3, LEFTY1,
ELMO3, PLA2G16, PIM2, ARHGEF5, IRF6, GLS2, PALM3, SLC37A1, FAM19A4, JAZF1,
C6orf132, LOC728377, SNAI3, SMPDL3B, FAM46B, CYP2S1, COL21A1, RHOV, PROCR,
EPS8L2, PPP1R1B, CRB3, SH2D3A, SNCB, STC2, ZDHHC23, C1orf172, KCNH5, LOC339524,
AASS, NPW, P2RX2, DHRS3, LAD1, PPAP2C, MAL2, SPP1, SLC27A6, USP43, LOC285484,
FBXO2, EREG, HSPA2, RAB19, VSTM2B, AGMAT, KLK1, SLC39A4, TMEM125, TSTD1,
LOC157627, RASGRP4, BSPRY, ANKRD24, SLC19A3, GFRA3, PYY, ESRG, FOXD3, GPC4, NOS1,
C1orf116, KCNK6, A2ML1, MATK, TRPM6, FERMT1, REPS2, TDGF1, LEFTY2, HEPHL1,
NCCRP1, SH3GL2, C1orf88, FGF4, ACAN, GABRD, FAM83F, ZNF296, ITGB1BP3, TERF1, ACP5,
CAT, HERC5, NIPAL1, MST1P9, SYT2, STAC2, PNPLA5, PRSS22, KCNK15, ESRP1, LOC643719,
TDGF1P3, PCP4L1, ACE, SLC2A14, CHST8, TRIB3, ICA1, C1orf210, C16orf11, GPR160, CLDN7,
BEND4, EHF, CTAGE4, TRIM58, TNFRSF8, CCNI2, ST14, ZNF860, ECHDC2, MMP3, MACC1,
SFRP5, LOC100506428, LPAR3, RIMS4, CBR3, OVOL1, SLC30A3, BHMT2, HEY2, BCAN,
MCOLN2, SLC4A11, VAV1, BHMT, INHBE, KLRG2, ZNF850, CHAC1, ZDHHC22, EPO, TNNC2,
ZMYND15, CA4, CHD5, COBL, ST8SIA5, C20orf118, GPR172B, RTBDN, ZNF513, CTAGE15P,
CBR1, MMP24, LOC100133286, MARVELD3, PTPRN, ZNF876P, CCDC64B, GPR64, BBS9,
ESRP2, RBP7, AIM1, UTF1, NAPRT1, FBXL21, SAMHD1, CABP1, TMEM151A, CR1L, HESX1,
C2orf65, HES2, EGFL6, ILDR1, CTSF, RPL39L, HMX1, ZNF493, TFCP2L1, CNTN1, PCDHB17,
PKP3, LOC730102, CXCL16, MYH2, LOC100288748, DNMT3B, CCNA1, CR2, NRN1L, FA2H,
TULP2, PROKR2, C1orf130, ANKRD34B, KLK13, C17orf107, HRASLS5, AP1M2, EVC2, SOX15,
ADAD2, LYPD5, LOC647946, LOC284408, TMEM215, MFSD6L, LOC100631378, PCDHB15,
DPPA2, TRDN, ZNF354C, SLFN12, SCIN, LOC84856, NLRP7, WIF1, MYOZ1, CSF3, NLRP2,
ZNF441, SCNN1G, C8orf47, HRH3, ZNF680, ALPK3, ZNF506, ZNF471, GABRG1, MGMT,
FLJ34208, ZNF799, ZNF585B, ERAS, ZNF440, ZNF443, ZNF229, ZNF528, ZNF454, CLEC4GP1,
SCNN1B, ZNF630, ZFP28, AGBL2, ZNF578, ZNF662, NR1I2, NNAT, CLEC4G, RAMP3, PCDHB5,
TCL1A, ZNF682, PIWIL2, LOC100128252, NAP1L6, KLHL34, LOC440910, ZNF433, ZNF135,
ZNF823, ZNF829, EPHX3, ZNF667, ZNF90, DPPA3, ZNF563, ZNF439, ZNF44, ZNF572,
ZNF442, ZNF69, ZNF502, ZNF429, LOC644554, RBM46, ZNF844, ZNF763, ZNF737, ZNF700,
MYH14, DPPA5, ZNF732, CST6, ZNF253, NUDT16P1, GPR114, TMEM30B, ZNF826P, ZNF835,
ZNF736, ZNF486, ZNF518A, ZNF626, ZSCAN1, LOC399815, MARVELD2, ZNF560, LY75,
ZNF788, MT1H, FOXI2, PEG3, ZNF492, ZNF93, CYP4F22, ZNF98, DCAF12L1, ZNF257,
LOC441666, LOC400680, LOC400655, ZNF208, ZFP42, ZNF878, NLRP4, ZNF99.
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